Cancer Research UK logo.
SearchDonate
  • Search

A trial of pembrolizumab and chemotherapy for triple negative breast cancer (KEYNOTE-355)

Overview

Cancer types:

Breast cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with triple negative breast cancer that has come back (recurrent) or spread to another part of the body (metastatic).

Triple negative breast cancers are cancers without for:

  • oestrogen

  • progesterone

  • HER2

Recruitment start: 27 July 2016

Recruitment end: 30 March 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Peter Schmid

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 31 Jul 2018

CRUK internal database number: 14853

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.